Sten Kramer, MD
Interventional Pain Medicine · Newport Beach, CANPI 1780783712
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,124 of the $10,638 with a category attached, or 85.8%. 39 manufacturers reported payments, led by Abbott at 34.8% of the total.
Across 270 payments — averaging $39.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Spinal Simplicity, LLC$1K
- Boston Scientific$1K
- Medtronic$831
- Nevro Corp.$520
- MML US, Inc.$397
- plus $3K from 33 others
What the payments were for
- Travel & lodging$1,48114%
- Food & beverage$9,12486%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 91 | $3,706 |
| Spinal Simplicity, LLC | 13 | $1,232 |
| Boston Scientific | 28 | $1,140 |
| Medtronic | 9 | $831 |
| Nevro Corp. | 21 | $520 |
| MML US, Inc. | 4 | $397 |
| Biotronik NRO, Inc. | 5 | $309 |
| Johnson & Johnson | 10 | $284 |
| Curonix LLC | 9 | $269 |
| Painteq LLC | 10 | $248 |
| Globus Medical | 2 | $169 |
| Scilex Pharmaceuticals Inc. | 8 | $135 |
| Miach Orthopaedics, Inc. | 1 | $126 |
| Pfizer | 7 | $124 |
| Stryker | 2 | $96 |
| Vertos Medical, Inc. | 2 | $95 |
| Bioventus LLC | 4 | $90 |
| Kowa Pharmaceuticals America, Inc. | 4 | $74 |
| Fidia Pharma USA Inc. | 4 | $71 |
| Amgen | 5 | $69 |
| Vericel Corporation | 3 | $65 |
| Forte Bio-pharma LLC | 3 | $64 |
| Si-bone, Inc. | 3 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $57 |
| Zyla Life Sciences, Inc. | 4 | $51 |
| GE HealthCare | 1 | $48 |
| Orthogenrx Inc. | 2 | $40 |
| Stimwave Technologies Incorporated | 2 | $36 |
| Averitas Pharma Inc. | 1 | $30 |
| BREG, Inc | 1 | $25 |
| IBSA Pharma Inc. | 1 | $25 |
| Linvatec Corporation | 1 | $24 |
| Surgenex LLC | 1 | $22 |
| DJO, LLC | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| GRT US Holding, Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Relievant Medsystems, Inc. | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,046
- INTELLIS$606
- PROCLAIM$457
- ReActiv8$341
- Senza Spinal Cord Stimulation System$176
- Prospera$148
- Senza$145
- GENERAL PAIN MANAGEMENT$100
How this compares
$10,638 in reported general payments places this provider in the 75th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 99 | $2,590 |
| Gabapentin | 120 | $2,217 |
| Etodolac | 66 | $1,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $721 |
| Duloxetine Hcl | 23 | $544 |
| Tizanidine Hcl | 62 | $528 |
| Pregabalin | 16 | $325 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $296 |
| Cyclobenzaprine Hcl | 29 | $283 |
| Meloxicam | 97 | $260 |
| Diclofenac Sodium | 14 | $119 |
| Tramadol Hcl | 19 | $51 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Newport Beach
- Balaji CharluNewport Beach$6K
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.